Marjanka Schmidt
Early detection
Shifting cancer care to an earlier stage
The earlier cancer is detected, the greater the opportunity to improve outcomes. Our researchers develop innovative technologies and personalized screening approaches to identify cancer at its earliest stages. Equally important, we aim to distinguish aggressive disease from lesions that can be safely monitored, reducing unnecessary treatment. Through close collaboration between research and clinical implementation, we work toward screening programs that are both effective and precise.
The Netherlands Cancer Institute, in collaboration with the AVL Center for Early Diagnostics, offers our researchers the best infrastructure to develop and optimize personalized screening and test novel techniques to detect cancer at an early stage of development.
We aim to translate fundamental knowledge into early detection programs to improve outcomes for cancer patients and eventually prevent cancer development.
Research into early detection
In this video, theme leader Marjanka Schmidt, PhD student Hristina Hristova, medical geneticist Irma van de Beek, and researcher Beatriz Carvalho show you their research into ways to detect cancer at an earlier stage. If the illness is detected early, treatment can be less invasive and the odds of recovery are higher.
Accept cookies to play the video
Related news and stories
Clinical research staff working on this theme:
- Muriel Adank
- Irma van de Beek
- Jacques Bergman
- Frank Borm
- Daan van den Broek
- Myriam Chalabi
- Jolanda van Dieren
- Caroline Drukker
- Nicole Kukutsch
- Monique van Leerdam
- Pim van Leeuwen
- Steven Linnebank
- Christianne Lok
- Ritse Mann
- Laura Mertens
- Iris van der Ploeg
- Elsemieke Plasmeijer
- Henk van der Poel
- Alexander Schmitz
- Nienke van Trommel